It struck me how much this mirrors life—and our work.
As clinicians, leaders, and caregivers, we often get absorbed in the granular details. We focus on the ground beneath our feet: documentation, drug interactions, staffing coverage, billing codes, and metrics. These are the roots and rocks of our path—absolutely necessary to navigate safely, but not the entire journey.
At other times, we glance back. We reflect on where we started, the progress we’ve made, and the milestones achieved. We celebrate how far our field has come: from cytotoxic chemotherapies to cell and gene therapies, from inpatient-centric models to robust outpatient networks, from pharmacists being considered support staff to essential providers and thought leaders. These backward glances matter. They ground us in history and hard work. But they are not enough.
What we must not forget—and what Taylor reminded us—is to look forward. To lift our eyes and ask: What’s next? Where are we going? Who’s being left behind?
Our collective hike in oncology pharmacy must include global vision. Although we have made tremendous strides in clinical advancements, those advancements remain inaccessible to large swaths of the world. Carolyn showed us women in Southeast Asia who travel hours for basic screening. She introduced us to families in sub-Saharan Africa navigating a cancer diagnosis without a single oncologist in their region. She highlighted the absence of infrastructure, medication, and education—needs that are solvable but not yet solved.
And here’s the uncomfortable truth: Even within our own communities, disparities persist. Geography, race, language, and income can all determine who gets treatment and how soon. The path forward demands that we look beyond our immediate surroundings.
As oncology pharmacists, we are uniquely positioned to help drive this progress. We are clinicians, yes—but we are also educators, innovators, researchers, policy advocates, and change makers. Each of us has a role to play.
The conference in Portland buzzed with examples of how we are already answering this call. From sessions on innovative research to presentations on the Big Idea, I was proud to see the energy in the room—curious, collaborative, and committed.
About the Editor in Chief
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, is a clinical pharmacy manager in the Blood and Marrow Transplant Program in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Cancer Center in Kansas City. Mahmoudjafari is a board-certified oncology pharmacist involved in several oncology-pharmacy organizations such as the Hematology/Oncology Pharmacy Association (HOPA), currently serving as secretary on the HOPA board of directors. She has also been the chair or co-chair of conferences such as Advanced Topics for Oncology Pharmacy Professionals Summit and Oncology Pharmacists Connect. In 2022, she was the recipient of the American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Lifetime Achievement Award and received the American Society of Clinical Oncology’s 40 Under 40 in Cancer Award.
Mahmoudjafari has presented nationally on her experience with managing high-cost therapies and on clinical topics such as cell and gene therapies, acute and chronic graft-vs-host disease, and the management of fungal infections in hematopoietic stem cell transplantation. Mahmoudjafari completed her pharmacy training at the University of Missouri-Kansas City (UMKC) and her PGY-1 pharmacy practice residency at The Ohio State University Wexner Medical Center. She completed her PGY-2 oncology residency at Huntsman Cancer Institute at the University of Utah and most recently received her master of business administration degree from Henry W. Bloch School of Management, which is affiliated with UMKC.
And while we explore these vast topics, we must also remember that the path ahead is not always linear. Just like a hike, our journey in oncology pharmacy includes switchbacks, detours, and moments where the climb feels steep. Progress is rarely immediate, and change never comes as fast as we want it to. But that’s OK. It’s not about racing to the end—it’s about remaining mindful on the trail ahead.
Looking down helps us stay grounded. Looking back helps us stay humble. But looking forward—looking up—keeps us inspired.
I encourage each of you to carry that spirit with you. What is one step you can take to lift someone else up? What is one thing you can do to make access easier, care safer, or your team stronger? What is one area where you can lift your eyes from the rocks and reimagine the landscape?
Maybe it is taking your expertise to a community clinic. Maybe it is advocating for policy change. Maybe it is reworking your practice model to incorporate patient voice more intentionally. Or maybe it is something smaller but just as powerful: mentoring a new practitioner, contributing to a publication, or showing up for your colleague who needs a little extra grace that day.
If Carolyn Taylor’s message taught us anything, it's this: Progress starts with people. Systems don’t change without human hearts behind them. And healing, whether in Kansas City or Kathmandu—requires more than medicine. It requires presence. It requires persistence. It requires vision.
To close, I return to that hiking trail on the Marquam and Flicker Trail Loop.
At one point during the hike, I looked back and I could see how every careful step—every pause, every push upward—had led us to that moment. And I realized something simple but profound: I had spent so much of that hike making sure I didn’t stumble that I almost forgot to take in the view.
Don’t forget to enjoy the view.
Don’t forget to honor how far you have come, even as you keep climbing.
And don’t forget to look up, because the summit may be just around the bend.
Here’s to more shared steps, hard climbs, and forward vision. Let’s keep walking together.
The views expressed in this article are the author's own and do not reflect the views of their employer.